TB-500 Side Effects and Safety
Reported TB-500 side effects, contraindications, and safety signals.
Safety & Contraindications
TB-500 is a research compound and is not FDA-approved for general use. It should be avoided by anyone with active malignancy and pregnancy. Most reported effects are mild and dose-dependent, so start at the low end of the dosing range and titrate up slowly rather than chasing a maximal dose. Injection-site redness, itching, or a temporary lump are the most common local reactions; rotate sites and use clean technique to keep them minimal.
What to Monitor
Track hs-CRP while you're running TB-500 so you can catch any drift early and adjust before it becomes a problem. Add these to your REGEN biomarker dashboard and re-check on your normal cadence.
Contraindications
- active malignancy
- pregnancy
References
- Thymosin beta4 and tissue regeneration · Goldstein AL, et al. · 2012
- Goldstein AL, Kleinman HK. Minireview: Crosstalk between thymosin β4 and the chemokine network. Ann N Y Acad Sci. 2015. · Martinez JO, Evangelopoulos M, Bhavane R, Acciardo S, Salvatore F, Liu X, Ferrari M, Tasciotti E · 2015
- Thymosin β4 Promotes Dermal Healing. · Kleinman HK, Sosne G · 2016
- Gene ResultTMSB4X thymosin beta 4 X-linked [ (human)] - NCBI
- Philp D, Kleinman HK. Animal studies with thymosin β4, a multifunctional tissue repair and regeneration peptide. Ann N Y Acad Sci. 2012. · Meyer M, Elmer S, Jäncke L · 2012
- Intra-Articular Injection of BPC 157 for Multiple Types of Knee Pain. · Lee E, Padgett B · 2021